share_log

双鹭药业(002038.SZ):利拉鲁肽处于三期整理数据阶段,报产时间暂不好估计

Shuanglu Pharmaceutical (002038.SZ): Liraglutide is in the third phase of data compilation, and the production time is not easy to estimate

Gelonghui Finance ·  Aug 4, 2023 04:47

Gelonghui, August 4?Some investors asked Shuanglu Pharmaceutical (002038.SZ), "how is the progress of the company's research and development of Lilaluptide, and when is it expected to be listed?"

Shuanglu Pharmaceutical replied that Lilarutide is in the third stage of data collation, and it is difficult to estimate the production time.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment